These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19360517)

  • 1. Placebo response in the treatment of women's sexual dysfunctions: a review and commentary.
    Bradford A; Meston CM
    J Sex Marital Ther; 2009; 35(3):164-81. PubMed ID: 19360517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comments on "the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women".
    Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():177-8. PubMed ID: 18783531
    [No Abstract]   [Full Text] [Related]  

  • 4. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg S
    J Sex Med; 2007 Mar; 4 Suppl 3():227-34. PubMed ID: 17394595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg SA; Simon JA; Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgenic hormones and aging--the link with female sexual function.
    Davison SL; Davis SR
    Horm Behav; 2011 May; 59(5):745-53. PubMed ID: 21215268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women.
    Rosen RC; Maserejian NN; Connor MK; Krychman ML; Brown CS; Goldstein I
    Menopause; 2012 Apr; 19(4):396-405. PubMed ID: 22076307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of placebo response in the treatment of sexual dysfunction in women: a preliminary report.
    Bradford A; Meston C
    J Sex Med; 2007 Sep; 4(5):1345-51. PubMed ID: 17666035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone therapy in women: a review.
    Bolour S; Braunstein G
    Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for women's sexual dysfunction.
    Basson R
    Expert Opin Pharmacother; 2009 Jul; 10(10):1631-48. PubMed ID: 19527189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives and libido in women.
    Davis AR; Castaño PM
    Annu Rev Sex Res; 2004; 15():297-320. PubMed ID: 16913282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone therapy for sexual dysfunction in postmenopausal women.
    Hubayter Z; Simon JA
    Climacteric; 2008 Jun; 11(3):181-91. PubMed ID: 18568783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status.
    Ito TY; Polan ML; Whipple B; Trant AS
    J Sex Marital Ther; 2006; 32(5):369-78. PubMed ID: 16959660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder.
    Caruso S; Agnello C; Intelisano G; Farina M; Di Mari L; Cianci A
    Urology; 2004 May; 63(5):955-9. PubMed ID: 15134988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
    Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
    Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicalization of women's sexual problems: a different story?
    Graham CA
    J Sex Marital Ther; 2007; 33(5):443-7. PubMed ID: 17674225
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of testosterone in the treatment of hypoactive sexual desire disorder.
    Schwenkhagen A; Studd J
    Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.